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Polymyxin P was isolated from a cultural broth of Bacillus polymyxa T-39 in 1969. 
Recent1y， we developed a new method to determine the chemical structure of N-fatty acyl 
peptide in combination with polymyxin acylase and a protein sequencer. Using this 
method， the chemical structures of polymyxin Pl and P2 were determined and their an-
tibacterial activities were c1arified. 
Introduction 
The discovery of polymyxins was announced in 
1947 simultaneously by three different groupsI):-3). 
These antibiotics were isolated from cultures of 
Bacillus polymyxa and B. aerosporus and shown 
to have a good spectrum of activity towards 
Gram-negative bacteria. Further studies4) revealed 
that they might be a group of chemically and 
biologically related polypeptides. In an attempt to 
clarify the situation， collaborative work5) was done 
by the three groups on the chemical and biological 
properties. As a result，‘polymyxin' was accepted 
as the generic name for this group of antibiotics 
and alphabetical suffixes were used to name 
different types that differed in their amino acid 
composition. Antibiotics isolated from different 
strains of B. polymyxa are named polymyxin 
A， B， C6)， D， E， K71 M8)， P， 81 and TI9). 
Similar antibiotics isolated from Bacillus species 
other than Bacillus polymyxa are named 
colistin10) (Aerobacillus colistinus)， circulinl) 
(B. circulans)， polymyxin P!2) (B. circulans 
ATCC 31228) and polypeptin13) (B. circulans). 
These antibiotics consist of two components， with 
each containing 6-methyl octanoic acid or iso-
octanoic acid as the N-terminal acyl group. In 
1969， Kimura et al isolated polymyxin P in our 
laboratory and reported this in a rapid short 
paperI4). The study of the chemical structure has 
continued and many polymyxin-type antibiotics 
have been found， as summarized in Table 1. 
Among them colistin and polymyxin B have been 
used clinically against bacterial infection. Recent-
ly， we developed a new method to determine the 
chemical structure of N-acyl peptide in combina-
tion with polymyxin acylase and protein sequen-
cer. Using this method， we tried to reveal the 
chemical structure of polymyxin P1 and P2・
This paper describes the fermentation， 
isolation， structural elucidation and antibacterial 
activities of polymyxin P1 and P2・
???
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Table 1. Comparison of constituent amino acids and fatty acids of polymyxins in literature 
Amino acid (ratio) 
Antibiotic Fatty acid 
A2bu Thr Leu Phe Ser Ile 
Polymyxin A1 5(L)，I(D) 3(L) I(D) MOA 
A2 5(L)，I(D) 3(L) I(D) IOA 
Polymyxin M1 6(L) 3(L) I(D) MOA 
恥12 6(L) 3(L) I(D) IOA 
polymyxin K 6(L) 3(L) I(D) +a 
Polymyxin B1 6(L) 2(L) I(L) I(D) MOA 
B2 6(L) 2(L) I(L) I(D) IOA 
Polymyxin C 十 + + + 
Polymyxin P 1 6 3 MOA 
P2 6 3 IOA 
Polymyxin D1 5(L) 3(L) I(L) I(D) MOA 
D2 5(L) 3(L) I(L) I(D) IOA 
Polymyxin E1 6(L) 2(L) I(L)，I(D) MOA 
(Colistin A) 
E2 6(L) 2(L) I(L)，I(D) IOA 
(Colistin B) 
Circurin A 6(L) 2(L) I(D) I(L) MOA 
B 6(L) 2(L) I(D) I(L) IOA 
Polymyxin Sl 5(L) 3(L) I(D) I(D) MOA 
Polymyxin T 1 6(L) I(L) 2(L) l(D) MOA 
Polymyxin F 5 2 MOA 
IOA 
MOA 6-methyl octanoic acid D: D-configuration 
IOA isooctanoic acid L : L-configuration 
a hydroxy fatty acid 十 Reportedto be present 
Materials and Methods 
Fermentation 
Bacil/us po!ymyxa T-39 was isolated from a soil 
sample collected at Suma-ku， Kobe City， Japan. 
A loopful of the organism on slant culture was 
transferred into four 5∞ーmlSakaguchi flasks each 
containing 100 ml of the seed medium. The 
medium contained 5070 corn meal， 1 % starch， 
0.1% yeast extract， 0.5% ammonium sulfate， 
O. 1 % potassium dihydrogenphosphate and 1 % 
calcium carbonate: The pH was adjusted to 7. 2 
before sterilization. The flasks were incubated on a 
rotary shaker (150 rpm) for 1 day at 28.C. The 
resulting culture was transferred into four 2ーliter
sterile Sakaguchi flasks each containing 500 ml of 
the seed medium. It was cultured for 3 days at 
28.C with aeration and at an agitation speed .of 
120 rpm. 
IsoIation and purification 
The isolation procedure outlined in Fig. 1 gave 
2. 1 g of the antibiotic acetate (light yellow pow-
der) from 2 liters of fermentation broth. The 
antibiotic， named polymyxin P， was separated two 
fractions， polymyxin P1 and P2， by using coun-
tercurrent distribution (solvent system， n-BuOH / 
sec-BuOH / O. 1 N HCl 6 / 30 / 40， transfer 
9∞times). These two fractions were collected 
and distilled off， and the residue was 
lyophilized， yielding 1，080 mg of polymyxin P1 
hydrochloride and 270 mg of P2 hydrochloride as 
a light yellow powder. 
Polymyxin P1 was purified by reversed-phase 
HPLC using a Y恥1C-Pack SH-343-10ーODS
column (25 x 2 cm i. d.， Yamamura Chemical 
Institute， Kyoto， Japan)， with isocratic elution 
with O. 1 M NaCI-HCl buff. (pH 2) in MeOH 
-H20 (5 / 45) and a flow rate of 4.0 ml / m泊uもe，
? ??
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Fig. 1. Isolation of polymyxin P from Bacillus polymyxa T -39 
and a variable-wavelength UV detector (875- acylase (0.13 U Wako Pure Chemicals， Ltd.) 
UV， Japan Spectroscopic， Tokyo， Japan， set at was added to 10/0 polymyxin Pt or P2 hydrochlo-
220 nm). The pH of the polymyxin Pt fraction ride (0.1 mI) solution (pH 8.0) at 37.C for 2 
was raised to 4 with 0.1 M NaOH. The sodium hours. After extraction of the liberated fatty 
chloride that formed was removed by applying acids， the water layer was adjusted to pH 4. O. 
Sephadex G-15 column (eluent water). The The desalted sample was subjected to preparative 
desalted solution was lyophilized， yielding 570 mg column chromatography [column: YMC-Pack AM 
of the main fraction of polymyxin P t hydrochlo- -324ー1かODS (30 x 1 cm i. d.)， mobile phase 
ride as a white powder. Also， purification of 0.01 M HCl in MeOH -H20 (5 / 95) ].The 
polymyxin P2 hydrochloride was carried out in the main fractions were collected and after neutralizing 
same manner as polymyxin P 1 ・ Onehundred fifty t h e s 0 1u t i 0 n w i t h O. 0 1 M N a 0 H， w e r e 
mg of polymyxin P2 hydrochloride as a white lyophilized， yielding DAPP1 or DAPP2・
powder was obtained. 
Amino acid sequence analysis 
Amino acid analysis The peptide sequences of DAPP1 and DAPP2 
Polymyxin Pt or P2 hydrocloride， 100 μg， was were determined with a pulse liquid-phase protein 
hydrolyzed with 50μ1 of constant-boiling sequencer (Applied Biosystems model 473A， Faster 
hydrochloric acid at 1100C for 18 hours. The City， CA， U. S. A.) from approximately 100 
hydrolyzate of polymyxin P1 or P2 was then ana- pmol of material. 
lyzed with a Hitachi L-8500 automatic amino acid 
analyzer. Gas chromatography of the fatty acids liberated 
from polymyxin Pt and P2 
Preparation of deacyl polymyxin Pt (DAPPt) and The ether fraction (see above) from polymyxin 
P2 (DAPP2) P1 or P2 was used to analyze fatty acids. Ether 
As described in previous papers l5 • 16)， polymyxin was removed by distillation， and the residue was 
?
?
??
?
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esterified with MeOH -BF3 and analyzed in GC 
using the following conditions: an OV-l column 
(2.1 m x 3.2 mm i.d. )， the flow rate of 50 ml 
/ minute for the carrier gas， an FID-detector. 
F AB mass spectra 
F AB mass spectra were obtained from a glycerol 
matrix with a JMS-DX 303 mass spectrometer 
(Jeol， Tokyo， Japan). 
Antibacterial activity 
The antibacterial potency determination was 
based on the agar-well method， modified from the 
official assay method for antibiotic preparation 
suggested by British Pharmacopoeia (1973). The 
minimum inhibitory concentrations of polymyxins 
P1 and P2 were determined by the twofold serial 
agar dilution method recommended by the Japan 
Society of Chemotherapy. The medium was 
Muller-Hinton agar. 
ResuIts and Discussion 
In the early stage， a homogeneous polymyxin 
purified by normal phase column chromatography 
could be separated into two or three components 
by a countercurrent distribution technique. Studies 
of the chemical structure of the polymyxin an-
tibiotics were carried out together with the prepa-
ration of penta N-2，4-dinitrophenyl polymyxins 
and their partial hydrolyzate. We had previously 
separated polymyxin P into polymyxin P1 and 
P2 by countercurrent distribution as shown in 
Fig. 1， and estimated their cyclic peptide structure 
by classical methods. These methods required large 
amounts of sample and long operation times. Aι 
ter that， itwas found that polymyxin P1 and 
polymyxin P2 could be easily separated by reversed 
phase (ODS) chromatography. Furthermore， ana-
lytical ODS column chromatography could separate 
the polymyxin P1 sample (which had been pre-
pared by countercurrent distribution) into 1 peaks 
(Fig. 2 (a)) and also the polymyxin P2 sample 
into 8 peaks (Fig. 2 (b) ). Table 2 shows the 
amino acid ratio constituting each peak. The ratio 
of A2bu (2， 4-diamino butyric acid) Thr Phe 
for peak 5 -1 in polymyxin P1 was approxi-
mately 6 3 1， respectively， and was the sむne
for peak 2 -8 inpolymyxin P2・ Peak1 was the 
main peak of polymyxin P1 (Fig. 2(a)) and peak 
4 for polymyxin P2・(Fig.2(b) As shown in 
Table 1， the amino acids constituting polymyxin 
C6) were the same as those of polymyxin P， but 
the amino acid ratio of polymyxin C has not been 
reported. As given below， the amino acid se-
quences of these fractionated compounds were the 
same. These results suggest that some adduct may 
be included by non-covalent bond in the cyc1ic 
peptide structure of each compound. The molecu-
lar ion [M+H]+ of polymyxin P1 by FAB-mass 
was 1191 and that of polymyxin P2 was 1177. 
(Fig. 3) These values agreed with the expected 
chemical structure of polymyxin P1 and P2， 
respectively. Some difference was observed in the 
mode of fragmentation between polymyxin P 1 and 
P2・Wesuppose that some adduct in polymyxin 
P1 is different from that of polymyxin P2・
Several years ago， we found a new enzyme， 
polymyxin acylase which hydrolyzes not only the 
N-terminal fatty acyl group of polymyxins， but 
also that of many N-fatty acyl peptides. Using 
this polymyxin acylase， we prepared DAPP1 and 
DAPP2・Theamino acid sequences of these de閉
acylated peptides were both A2bu→ Thr→ A2bu 
→ none → A2bu→ Phe→ Thr→ A2bu→ 
A2bu→ Thr. This structure corresponded to that 
expected for DAPP1 and DAPP2 by the classical 
method. The peptide sequence of other fractions 
having the same amino acid ratio (A2bu Thr 
Phe 6 3 1) was the same as that of main 
fraction. In this sequence， no amino acid was 
detected in the fourth cyc1e， indicating that poly-
myxin P had preserved its cyclic structure (the 
amide linkage between the r-amino group of the 
A2bu residue of the fourth cyc1e and the carboxyl 
group of C-terminal Thr). Gas chromatographic 
analysis of the liberated fatty acid from polymyxin 
P1 and P2 gave different results. The fatty acid 
from polymyxin P 1 was optically active and was 
identical with authentic 6-methyl octanoic acid. On 
-40-
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Table 2. Amino acid analysis of polymyxin P1 and P2 
? ，
?
? ?????????Polymyxin P1 
Peak No. Phe 
?
?
??
????
『??
? ? ?
?? ? ? ? ?
Thr 
1.92 
2.58 
2.89 
3.01 
2.99 
2.12 
2.45 
3.05 
A2bu 
3.75 
7.07 
7.28 
6.83 
7.18 
6.18 
5.93 
6.60 
Phe 
?
??
?
??
??
?
?「??
?????
?
?
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.0。
Thr 
1.40 
1.61 
1.57 
1.57 
2.91 
2.78 
2.79 
2.93 
2.88 
2.73 
2.86 
A2bu 
3.61 
3.08 
3.19 
3.38 
6.57 
6.30 
6.30 
6.46 
6.44 
5.90 
6.52 
The antibacterial spectra of polymyxin P1 and 
P2 were similar to those of polymyxin B. (Table 
3) They were strongly active against Gram-negative 
bacteria， such as Escherichia coli， Klebsiella pneu-
moniae， and Pseudomonas aeruginosa， and the 
-41-
the other hand， that from polymyxin P2 was op-
tically inactive and identical with authentic iso-
octanoic acid. Thus， the chemical structures of 
polymyxin P1 and P2 were determined as shown in 
Fig. 4. 
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Fig. 3. FAB-mass spectra of polymyxin Pl (a) and P2 (b) 
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Fig. 4. Structure of polymyxin P1 and P2 
antibacterial potency of polymyxin P1 was higher with a short operation time (about one day). This 
than that of polymyxin P2・ methodshould be very useful for determining the 
In this work， we developed. a new method to chemical structure of many N-acyl cyclic peptides. 
determine the chemical structure of polymyxin an-
tibiotics using a small amount of sample (I mg) 
????
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Table 3. Antimicrobial spectrum and potencies of polymyxin P， and P2 
MIC (μg/ml) 
P， P2 Complex Polymyxin B 
1.56 3.12 0.78 1.56 
1.56 3.12 0.78 0.39 
0.78 0.78 0.78 0.39 
12.5 6.25 3.12 3.12 
12.5 6.25 3.12 3.12 
12.5 6.25 3.12 3.12 
100 >100 100 100 
100 100 100 100 
8，090 1，800 6，760 8，000 
Test organism 
Escherichia coli 
$lebsiella pneumoniae 
Shigella sonnei I 
Pseudomonas aeruginosa 
P.αeruginosa P2 
P. aeruginosa P3 
Staphyrococcus aureus 
Bacillus subtilis 
Potency (U/mg) 
Medium Modified Muller Hinton agar 
Inoculum One loopful of 106 cfu/ml suspension of each strain. 
Potency (U/mg) expressed as polymyxin B units. 
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